17327487|t|GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models.
17327487|a|6-[(3-Cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-N-methyl-3-pyridinecarboxamide hydrochloride (GSK189254) is a novel histamine H(3) receptor antagonist with high affinity for human (pK(i) = 9.59 -9.90) and rat (pK(i) = 8.51-9.17) H(3) receptors. GSK189254 is >10,000-fold selective for human H(3) receptors versus other targets tested, and it exhibited potent functional antagonism (pA(2) = 9.06 versus agonist-induced changes in cAMP) and inverse agonism [pIC(50) = 8.20 versus basal guanosine 5'-O-(3-[(35)S]thio)triphosphate binding] at the human recombinant H(3) receptor. In vitro autoradiography demonstrated specific [(3)H]GSK189254 binding in rat and human brain areas, including cortex and hippocampus. In addition, dense H(3) binding was detected in medial temporal cortex samples from severe cases of Alzheimer's disease, suggesting for the first time that H(3) receptors are preserved in late-stage disease. After oral administration, GSK189254 inhibited cortical ex vivo R-(-)-alpha-methyl[imidazole-2,5(n)-(3)H]histamine dihydrochloride ([(3)H]R-alpha-methylhistamine) binding (ED(50) = 0.17 mg/kg) and increased c-Fos immunoreactivity in prefrontal and somatosensory cortex (3 mg/kg). Microdialysis studies demonstrated that GSK189254 (0.3-3 mg/kg p.o.) increased the release of acetylcholine, noradrenaline, and dopamine in the anterior cingulate cortex and acetylcholine in the dorsal hippocampus. Functional antagonism of central H(3) receptors was demonstrated by blockade of R-alpha-methylhistamine-induced dipsogenia in rats (ID(50) = 0.03 mg/kg p.o.). GSK189254 significantly improved performance of rats in diverse cognition paradigms, including passive avoidance (1 and 3 mg/kg p.o.), water maze (1 and 3 mg/kg p.o.), object recognition (0.3 and 1 mg/kg p.o.), and attentional set shift (1 mg/kg p.o.). These data suggest that GSK189254 may have therapeutic potential for the symptomatic treatment of dementia in Alzheimer's disease and other cognitive disorders.
17327487	0	9	GSK189254	Chemical	MESH:C521312
17327487	82	101	Alzheimer's disease	Disease	MESH:D000544
17327487	274	283	GSK189254	Chemical	MESH:C521312
17327487	296	319	histamine H(3) receptor	Gene	11255
17327487	354	359	human	Species	9606
17327487	385	388	rat	Species	10116
17327487	425	434	GSK189254	Chemical	MESH:C521312
17327487	465	470	human	Species	9606
17327487	609	613	cAMP	Chemical	-
17327487	664	706	guanosine 5'-O-(3-[(35)S]thio)triphosphate	Chemical	-
17327487	723	728	human	Species	9606
17327487	803	818	[(3)H]GSK189254	Chemical	-
17327487	830	833	rat	Species	10116
17327487	838	843	human	Species	9606
17327487	910	914	H(3)	Chemical	MESH:C012616
17327487	991	1010	Alzheimer's disease	Disease	MESH:D000544
17327487	1126	1135	GSK189254	Chemical	MESH:C521312
17327487	1163	1229	R-(-)-alpha-methyl[imidazole-2,5(n)-(3)H]histamine dihydrochloride	Chemical	-
17327487	1231	1260	[(3)H]R-alpha-methylhistamine	Chemical	-
17327487	1306	1311	c-Fos	Gene	2353
17327487	1419	1428	GSK189254	Chemical	MESH:C521312
17327487	1473	1486	acetylcholine	Chemical	MESH:D000109
17327487	1488	1501	noradrenaline	Chemical	MESH:D009638
17327487	1507	1515	dopamine	Chemical	MESH:D004298
17327487	1553	1566	acetylcholine	Chemical	MESH:D000109
17327487	1674	1697	R-alpha-methylhistamine	Chemical	MESH:C069357
17327487	1706	1716	dipsogenia	Disease	
17327487	1720	1724	rats	Species	10116
17327487	1753	1762	GSK189254	Chemical	MESH:C521312
17327487	1801	1805	rats	Species	10116
17327487	2030	2039	GSK189254	Chemical	MESH:C521312
17327487	2104	2112	dementia	Disease	MESH:D003704
17327487	2116	2135	Alzheimer's disease	Disease	MESH:D000544
17327487	2146	2165	cognitive disorders	Disease	MESH:D003072
17327487	Positive_Correlation	MESH:C521312	2353
17327487	Association	MESH:C521312	MESH:D003072
17327487	Positive_Correlation	MESH:C521312	MESH:D000109
17327487	Positive_Correlation	MESH:C521312	MESH:D009638
17327487	Association	MESH:C521312	MESH:D000544
17327487	Positive_Correlation	MESH:C521312	MESH:D004298
17327487	Negative_Correlation	MESH:C521312	11255
17327487	Association	MESH:C012616	MESH:D000544

